Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
66.69
+0.10 (+0.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
47
48
Next >
A Look Into Gilead Sciences's Debt
October 31, 2022
Over the past three months, shares of Gilead Sciences Inc. (NASDAQ:GILD) rose by 26.52%. Before we understand the importance of debt, let's look at how much debt Gilead Sciences has.
Via
Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
Gilead Sciences (GILD) Q3 2022 Earnings Call Transcript
October 27, 2022
GILD earnings call for the period ending September 30, 2022.
Via
The Motley Fool
With A Breakout On The Line, Gilead Sciences Reports Massive Cancer Drug Sales
October 27, 2022
Gilead stock is approaching a buy point out of a saucer base.
Via
Investor's Business Daily
Healthcare & Biotech Stocks: A Big Opportunity In 2023
October 30, 2022
One of the areas that will come with opportunities for stock market investors in 2023 is the health care sector. This includes pharma, medical devices, biotech, and the likes.
Via
Talk Markets
These 2 Stock Winners Topped Apple's Big Gains Friday
October 28, 2022
Strong earnings helped lift the market.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Check Out What Whales Are Doing With GILD
October 28, 2022
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list...
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday
October 28, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Upgrades
Via
Benzinga
Analysts Turn Bullish On Gilead After Q3 Earnings Surpass Expectations
October 28, 2022
Via
Benzinga
Where Gilead Sciences Stands With Analysts
October 28, 2022
Over the past 3 months, 8 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
October 28, 2022
Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday.
Via
Benzinga
Why Gilead Sciences Stock Is Rising After Hours
October 27, 2022
Gilead Sciences Inc (NASDAQ: GILD) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected
Via
Benzinga
Gilead Sciences Announces Third Quarter 2022 Financial Results
October 27, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities
October 24, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
October 21, 2022
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 7.45% on an annualized basis producing an average annual return of 14.87%. Currently, Gilead Sciences has a market...
Via
Benzinga
Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene Expression Platform for Blood Cancers
October 20, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
October 19, 2022
Reuters US Lawmakers Plan Hearing On Kroger, Albertsons' $25B Merger
Via
Benzinga
US Sends Gilead's COVID-19 Antiviral To Safeguard Health Workers In Uganda Ebola Outbreak
October 19, 2022
The U.S. sent Gilead Sciences Inc's (NASDAQ: GILD) remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda as a response to the Ebola outbreak.
Via
Benzinga
Europe Approves First CAR T-Cell Therapy For B-Cell Lymphoma In 30 Years to Improve Upon Standard of Care
October 18, 2022
Via
Benzinga
Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022
October 18, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
Kite’s Yescarta First CAR T-cell Therapy to Receive European Marketing Authorization for Use in Second-Line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
October 17, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
MacroGenics Shares Jump On Gilead Licensing Pact For Blood Cancer Candidates
October 17, 2022
Via
Benzinga
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies
October 17, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
October 16, 2022
All three of these medical stocks offer a high-yield dividend.
Via
The Motley Fool
Why Cash-Rich Companies And #ETFs Are Beating The Market?
October 15, 2022
Investors believe that “cash is king” in the current environment of surging inflation, rising rates, and a potential economic downturn. ETFs that hold cash-rich companies have seen a lot of interest...
Via
Talk Markets
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
47
48
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.